Correlation Between Verint Systems and Nu Med
Can any of the company-specific risk be diversified away by investing in both Verint Systems and Nu Med at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Verint Systems and Nu Med into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Verint Systems and Nu Med Plus, you can compare the effects of market volatilities on Verint Systems and Nu Med and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Verint Systems with a short position of Nu Med. Check out your portfolio center. Please also check ongoing floating volatility patterns of Verint Systems and Nu Med.
Diversification Opportunities for Verint Systems and Nu Med
-0.54 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Verint and NUMD is -0.54. Overlapping area represents the amount of risk that can be diversified away by holding Verint Systems and Nu Med Plus in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nu Med Plus and Verint Systems is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Verint Systems are associated (or correlated) with Nu Med. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nu Med Plus has no effect on the direction of Verint Systems i.e., Verint Systems and Nu Med go up and down completely randomly.
Pair Corralation between Verint Systems and Nu Med
Given the investment horizon of 90 days Verint Systems is expected to generate 0.28 times more return on investment than Nu Med. However, Verint Systems is 3.54 times less risky than Nu Med. It trades about 0.07 of its potential returns per unit of risk. Nu Med Plus is currently generating about -0.1 per unit of risk. If you would invest 2,356 in Verint Systems on October 5, 2024 and sell it today you would earn a total of 319.00 from holding Verint Systems or generate 13.54% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Verint Systems vs. Nu Med Plus
Performance |
Timeline |
Verint Systems |
Nu Med Plus |
Verint Systems and Nu Med Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Verint Systems and Nu Med
The main advantage of trading using opposite Verint Systems and Nu Med positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Verint Systems position performs unexpectedly, Nu Med can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nu Med will offset losses from the drop in Nu Med's long position.Verint Systems vs. Evertec | Verint Systems vs. Consensus Cloud Solutions | Verint Systems vs. Global Blue Group | Verint Systems vs. NetScout Systems |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |